Baird Financial Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,344
Closed -$32.1K 1831
2025
Q4
$32.1K Sell
11,344
-353,079
-97% -$1.82M ﹤0.01% 1783
2025
Q3
$2.54M Sell
364,423
-35,317
-9% -$249K ﹤0.01% 968
2025
Q2
$2.37M Sell
399,740
-44,540
-10% -$256K ﹤0.01% 958
2025
Q1
$2.84M Buy
444,280
+43,149
+11% +$416K 0.01% 857
2024
Q4
$4.77M Buy
401,131
+57,039
+17% +$972K 0.01% 691
2024
Q3
$9.53M Sell
344,092
-57,267
-14% -$1.43M 0.02% 522
2024
Q2
$9.57M Sell
401,359
-34,157
-8% -$802K 0.02% 491
2024
Q1
$7.67M Buy
435,516
+578
+0.1% +$8.52K 0.02% 546
2023
Q4
$6.86M Sell
434,938
-43,233
-9% -$446K 0.02% 567
2023
Q3
$4.11M Sell
478,171
-18,368
-4% -$130K 0.01% 677
2023
Q2
$3.92M Buy
496,539
+39,525
+9% +$275K 0.01% 691
2023
Q1
$3.4M Sell
457,014
-21,655
-5% -$215K 0.01% 714
2022
Q4
$5.64M Buy
478,669
+29,746
+7% +$340K 0.01% 548
2022
Q3
$4.14M Buy
448,923
+56,618
+14% +$686K 0.01% 617
2022
Q2
$3.88M Sell
392,305
-12,814
-3% -$259K 0.01% 639
2022
Q1
$14M Buy
405,119
+33,356
+9% +$1.08M 0.03% 378
2021
Q4
$18.5M Buy
371,763
+471
+0.1% +$24.8K 0.04% 330
2021
Q3
$17.1M Buy
371,292
+12,287
+3% +$487K 0.04% 330
2021
Q2
$10.7M Buy
359,005
+21,199
+6% +$433K 0.03% 407
2021
Q1
$6.87M Buy
337,806
+81,042
+32% +$1.71M 0.02% 488
2020
Q4
$4.29M Buy
256,764
+1,277
+0.5% +$16.8K 0.01% 583
2020
Q3
$2.8M Buy
255,487
+2,129
+0.8% +$16.8K 0.01% 645
2020
Q2
$1.67M Buy
253,358
+131,061
+107% +$841K 0.01% 779
2020
Q1
$751K Buy
+122,297
New +$993K ﹤0.01% 950

Other funds holding ASPN

Baird Financial Group's ASPN Position: Q1 2026 in Review

Baird Financial Group sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 11,344 shares — an estimated $32.1K sold.

Baird Financial Group first reported a position in ASPN in Q1 2020 and held it in 24 quarters. The position peaked at $18.5M in Q4 2021. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Baird Financial Group reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Baird Financial Group sold 11,344 Aspen Aerogels shares in Q1 2026, an estimated $32.1K.
  • Baird Financial Group first reported a position in Aspen Aerogels in Q1 2020 and held it in 24 quarters.
  • Baird Financial Group's Aspen Aerogels position peaked at $18.5M in Q4 2021.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.